Safety and efficacy of a single intra-articular injection of a novel enhanced protein solution (JTA-004) compared to hylan G-F 20 in symptomatic knee osteoarthritis: a randomized, double-blind, controlled phase II/III study

Table 1 Description of the three administered JTA-004 formulations

JTA-004 formulation	Plasma protein solution		Clonidine		HA		Volume of injection
JTA-004 formulation	Concentration	Amount	Concentration	Amount	Concentration	Amount	Volume of injection
JTA-100/2	1.02 g/ml	2.04 g	50 μg/ml	100 μg	10 mg/ml	20 mg	2 ml
JTA-200/2	1.02 g/ml	2.04 g	100 μg/ml	200 μg	10 mg/ml	20 mg	2 ml
JTA-200/4	1.02 g/ml	4.08 g	50 μg/ml	200 μg	10 mg/ml	40 mg	4 ml

ISSN: 1471-2474